-
Uncategorized1 week agoSTAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program
WASHINGTON — Leaders at the Food and Drug Administration on Thursday listened to criticisms and recommendations for how to move forward with a speedy drug review...
-
Uncategorized1 week ago
Experimental Adjuvant Could Strengthen Mucosal Immunity with Injectable Polio Vaccines
The injectable form of the polio vaccine has proven effective at preventing illness but it does not block the transmission of the virus as well as...
-
Uncategorized1 week agoSTAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
The Supreme Court unanimously ruled that Hikma Pharmaceuticals did not infringe patents held by Amarin in a decision that makes generic drugmakers less vulnerable to lawsuits...
-
Uncategorized1 week agoSTAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
Amy Johnston is distraught and readily admits that she is “grasping at straws.” Diagnosed last year with pancreatic cancer, she has had chemotherapy and surgery and...
-
Uncategorized1 week agoSTAT+: RFK Jr.’s second year: Vacancies, not vaccines
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Uncategorized1 week ago
Massachusetts’ life sciences employment dipped last year following 14 years of growth: report
Massachusetts’ life sciences jobs declined 1% in 2025, according to a new MassBioEd report. However, the report is projecting industry employment will increase 9.7% by 2030....
-
Uncategorized1 week agoFDA grants Orphan Drug Designation to osteosarcoma treatment
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation to a treatment for osteosarcoma. SOT106, developed by biopharmaceutical company SOTIO Biotech, is a next-generation antibody-drug conjugate...
-
Uncategorized1 week agoAlnylam, Inceptive ink AI deal potentially worth $2B
The RNA-focused drugmaker says Inceptive’s tools will help prioritize the best development options as well as speed up the research process.
-
Uncategorized1 week ago
Lilly and Boehringer roll back billions in German investments over health budget cuts
Lilly and Boehringer roll back billions in German investments over health budget cuts
-
Uncategorized1 week agoSTAT+: AI titans push Congress for DNA safeguards
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The inventor of some of...
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
An obesity drug deep-dive, and peptides move mainstream
